← Back to Clinical Trials
Recruiting NCT07026773

NCT07026773 Validity of ICU Clinician's Appraisal of Proportionality in CPR

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07026773
Status Recruiting
Phase —
Sponsor University Hospital, Ghent
Condition Cardiac Arrest, Out-Of-Hospital
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-05-18
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2025-05-18 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The VICAP-CPR study investigates whether doctors and nurses working in Intensive Care can determine neurological outcome and future quality of life after six months in patients treated for cardiac arrest outside the hospital based on clinical assessment in the first 24 hours after admission to Intensive Care. To conduct this study, the results of the questionnaire offered to Intensive Care doctors and nurses regarding the estimation of long-term neurological outcome and quality of life will be compared with the neurological outcome and quality of life as recorded in the STEPCARE study (NCT 05564754). The aim of the international STEPCARE study is to determine the best combination of post-resuscitation care to favourably influence survival and neurological outcome in patients treated for cardiac arrest outside hospital.

Eligibility Criteria

Inclusion Criteria: * Doctors and nurses working in the Intensive Care Unit treating patients included in the STEPCARE study (NCT 05564754) Exclusion Criteria: * Doctors and nurses who do not have a direct treatment relationship with a patient included in the STEPCARE study

Contact & Investigator

Central Contact

Patrick Druwé, MD, PhD

✉ patrick.druwe@uzgent.be

📞 003293321387

Frequently Asked Questions

Who can join the NCT07026773 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest, Out-Of-Hospital. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07026773 currently recruiting?

Yes, NCT07026773 is actively recruiting participants. Contact the research team at patrick.druwe@uzgent.be for enrollment information.

Where is the NCT07026773 trial being conducted?

This trial is being conducted at Innsbruck, Austria, Genk, Belgium, Ghent, Belgium, Helsinki, Finland and 5 additional locations.

Who is sponsoring the NCT07026773 clinical trial?

NCT07026773 is sponsored by University Hospital, Ghent. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology